This inventor holds 3 USPTO granted patents. Top assignee: Croda International, Inc.. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Innovations by Laurent Duroux
Introduction
Laurent Duroux is a notable inventor based in Bronshoj, Denmark. He has made significant contributions to the field of vaccine adjuvants and biomolecule delivery systems. With a total of 3 patents, his work is paving the way for advancements in medical technology.
Latest Patents
One of his latest patents is titled "Filamentous nanoparticles having vaccine adjuvant effect." This invention relates to thread-like nanoparticles that comprise sterol and a component derived from Molina, specifically quillaja acid and quillaja saponin. The invention focuses on the use of these nanoparticles in vaccines and drug delivery systems, highlighting their potential as vaccine adjuvants and in cancer therapy.
Another significant patent is "Phytates for use as a biomolecules delivery or adsorption system." This invention involves mineral micro-particles that comprise phytate (inositol hexaphosphate, IP6). It provides salts of phytic acid with multivalent metal ions such as calcium and magnesium for use in biomolecule delivery systems, emphasizing their application as vaccine adjuvants.
Career Highlights
Laurent Duroux is currently associated with Croda International, Inc., where he continues to innovate in the field of biomedicine. His work is characterized by a strong focus on developing new materials that enhance the efficacy of vaccines and therapeutic agents.
Collaborations
He collaborates with esteemed colleagues such as Kefei Hu and Erik Lindblad, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Laurent Duroux's contributions to the field of vaccine adjuvants and biomolecule delivery systems are noteworthy. His innovative patents reflect a commitment to advancing medical technology and improving health outcomes.